| Dr Marlin L Christianson, MD | |
|
475 West 940 North, Provo, UT 84604 | |
| (801) 357-7930 | |
| (801) 357-7014 |
| Full Name | Dr Marlin L Christianson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 475 West 940 North, Provo, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023124781 | NPI | - | NPPES |
| 942854058788-D6001 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 329427-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Utah Valley Hospital | Provo, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
At this point in the pandemic, most parents are familiar with "covid notification" letters. But the letters' instruction on whether your kid must quarantine or not varies wildly from school to school.
On Nov. 21, 2019, the U.S. Food and Drug Administration approved the use of the drug acalabrutinib for first-line therapy in chronic lymphocytic leukemia and small cell lymphoma.
Peter Meylakhs, from HSE University - St. Petersburg, together with colleagues from Georgia State University (USA) and Tarbiat Modares University (Tehran), have developed the HIV-PWID Policy Index (HPPI)-an international policy index for HIV prevention among people who inject drugs.
A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
At this point in the pandemic, most parents are familiar with "covid notification" letters. But the letters' instruction on whether your kid must quarantine or not varies wildly from school to school.
On Nov. 21, 2019, the U.S. Food and Drug Administration approved the use of the drug acalabrutinib for first-line therapy in chronic lymphocytic leukemia and small cell lymphoma.
Peter Meylakhs, from HSE University - St. Petersburg, together with colleagues from Georgia State University (USA) and Tarbiat Modares University (Tehran), have developed the HIV-PWID Policy Index (HPPI)-an international policy index for HIV prevention among people who inject drugs.
A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marlin L Christianson, MD 475 West 940 North, Provo, UT 84604 Ph: (801) 357-7930 | Dr Marlin L Christianson, MD 475 West 940 North, Provo, UT 84604 Ph: (801) 357-7930 |
News Archive
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
At this point in the pandemic, most parents are familiar with "covid notification" letters. But the letters' instruction on whether your kid must quarantine or not varies wildly from school to school.
On Nov. 21, 2019, the U.S. Food and Drug Administration approved the use of the drug acalabrutinib for first-line therapy in chronic lymphocytic leukemia and small cell lymphoma.
Peter Meylakhs, from HSE University - St. Petersburg, together with colleagues from Georgia State University (USA) and Tarbiat Modares University (Tehran), have developed the HIV-PWID Policy Index (HPPI)-an international policy index for HIV prevention among people who inject drugs.
A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers.
› Verified 8 days ago
Dr. Robert Joel Bush, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 750 N Freedom Blvd Ste 300, Provo, UT 84601 Phone: 801-852-1443 | |
Janee Namealoha Sells, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3200 N Canyon Rd Ste C, Provo, UT 84604 Phone: 385-375-8724 | |
Tyson Schwab, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 395 W Bulldog Blvd Ste 205, Provo, UT 84604 Phone: 801-357-1770 | |
Mr. Gregory Lawrence Nielsen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1750 N Wymount Terrace Dr, Provo, UT 84604 Phone: 801-422-2771 Fax: 801-422-0761 | |
Mr. Tyler Jason Fieldsted, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 W 940 N, Provo, UT 84604 Phone: 801-357-7926 Fax: 801-357-7927 | |
Dr. Matthew Craig Evans, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1157 N 300 W, #201, Provo, UT 84604 Phone: 801-581-2000 |